XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Condensed Consolidated Statements of Income and Comprehensive Income (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 105 Months Ended
Mar. 31, 2022
Mar. 31, 2023
Mar. 31, 2022
Sep. 25, 2031
Net sales $ 42,373 $ 118,121 $ 118,440 $ 32,699
Cost of goods sold 34,980 105,160 96,220 31,323
Gross profit 7,393 12,961 22,220 1,376
Selling, general and administrative 4,119 11,422 12,317 3,864
(Loss) income from operations 3,274 1,539 9,903 (2,488)
Other (expense) income:        
Interest income 0 25 0 12
Interest expense (19) (246) (45) (116)
Foreign exchange loss (40) (484) (35) (194)
Other, net (29) (18) (43) (2)
Total other expense (88) (723) (123) (300)
(Loss) income before income taxes 3,186 816 9,780 (2,788)
(Benefit) provision for income taxes 682 331 2,173 (407)
Net (loss) income 2,504 485 7,607 (2,381)
Unrealized (loss) gain resulting from change in fair value of derivative instruments, net of tax 474 (1,621) 1,759 (357)
Comprehensive (loss) income $ 2,978 $ (1,136) $ 9,366 $ (2,738)
Net (loss) income per common share:        
Basic (in dollars per share) $ 0.42 $ 0.08 $ 1.23 $ (0.41)
Diluted (in dollars per share) $ 0.41 $ 0.08 $ 1.22 $ (0.41)
Weighted average common shares outstanding        
Basic (in shares) 6,003,036 5,867,400 6,167,539 5,816,058
Diluted (in shares) 6,041,424 5,885,116 6,216,422 5,816,058